Screen Reader Access



Notices

Cancellation of the position of Project Associate-I against advt. no. 03(P07)/2024 New

Walk-in-interview for engagement of Project Staff under different Projects against Advt No.08/2024 New

Result of the position of Project Associate (PAT-I) against Advt no. 06/2024 New

Link for Downloading marks obtained by the candidates in the written examination for the Post of Driver vide Advt No. 04/2024 New

Shortlisted Candidates for Project Associate-I (Post Code-01) against Advertisement No. 07/2024 New

Result of the position of Project Staff (PC-01 to 06) against Advt no. 07/2024 New

Cancellation of the position of Project Associate-I against advt. no. 03(P09)/2024 New

Result for the position of Project Staff (PC-08) against Advt. no. 06/2024 New

Shortlisted Candidates for Project Associate-I (Post Code-02) against Advertisement No. 07/2024 New

Result of the position of Project Staff (PC-14) against Advt. no. 06/2024 New

Result for the post of Driver against Advt. no. 04/2024 New

Answer Keys of Written Examination for the Post of Driver vide Advertisement No. 04/2024 New

Shortlisted Candidates for PA-I against Advertisement No. 03(P12)/2024 New

Shortlisted candidates list for CSIR-CDRI-AcSIR PhD Program (January 2025) New

Result of the position of Project Staff (PC-07) against Advt. no. 06/2024 (Online) New

Shortlisted Candidates for Project Associate-I against Advertisement No. 3(P28)/2024 New

Shortlisted Candidates for Project Associate-I against Advertisement No. 03(P6)/2024 New

Answer Keys of Written Examination held on 11th Nov., 2024 for the Post of Driver vide Advertisement No. 04/2024 New

Result of the skill test conducted on 10th Nov., 2024 for the post of driver against advertisement no. 04/2024 New

Result of the Position Code 1 to 11 for Project Staff against Advt. no. 06/2024 (Walk-In-Interview) New

Result of the Position Code 12 to 21 for Project Staff against Advt. no. 06/2024 (Walk-In-Interview) New

Result of the position of Project Technical Support-III (PC-04 and 05 online mode) against Advt. no. 06/2024 New

|| AnnexureNew

Archive NoticesNew


Message from Director


Dr. Radha Rangarajan

Director, CSIR-CDRI


Research Areas

CDRI
CSIR-CDRI

Development of new drugs/drug combinations as therapeutic interventions for malaria, leishmaniasis and filariasis

Development of new drugs/drug combinations as therapeutic intervention for malaria, leishmanial and filariasis


Identification of unique targets and pathways for future interventions


Investigations on parasite biology and host-parasite interactions.

cdri
CSIR-CDRI

Development of novel agents for fracture healing and management of osteoporosis through modern drug design..

Development of novel agents for fracture healing and management of osteoporosis through modern drug design, scientific validation of traditional remedies and generation of new knowledge

CDRI
cdri

The World Health Organization has defined Antimicrobial resistance as the ability of a microorganism to stop an antimicrobial from working against it..

The World Health Organization(WHO) has defined Antimicrobial resistance (AMR) as the ability of a microorganism to stop an antimicrobial from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others. It has further stated “AMR is of particular concern in developing nations, including India, where the burden of infectious disease is high and healthcare spending is low. The country has among the highest bacterial disease burden in the world. Antibiotics, therefore, have a critical role in limiting morbidity and mortality in the country.

CDRI
CSIR-CDRI

Affordable drugs for lifestyle diseases (CVS,CNS and related disorders) to achieve the dream “SWASTH BHARAT”

As per the estimates in the WHO non communicable disease (NCD) Country Profile 2014, Cardio- vascular disease (CVD) is the leading cause of Deaths in India and accounts for 26% of all deaths. As per WHO more than 4% of Indian population (3rd in world after USA and China) is obese, which is the main reason of major CVDs. In 2008, WHO declared dementia/AD as a priority condition through the Mental Health Gap Action Programs


cdri
CSIR-CDRI

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female)..

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female) and management of endocrine disorders through modern drug design, scientific validation of traditional remedies

CDRI
cdri

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn ...

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn metamorphose to flagellated spermatozoa that mature in the epididymis. To characterize the dynamics of gene expression during these important stages of spermatogenesis, undertook transcriptome analysis in >90% pure pachytene spermatocytes and round spermatids, and pure mature sperm of rat by massive parallel deep sequencing.

CDRI
CSIR-CDRI

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

cdri
cdri

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance..

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance, international relevance and public health needs


Continued engagement with drug regulation and pharmaceutical policy making in India as well as internationally

Our Drugs

E-MAL Arteether

For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.

Keen Mind Bacopa Extract

Keenmind is marketed through Soho Flordis International, Sydney, Australia and is available now in India.

Saheli Centchroman

First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.

Reunion Dalzbone

Success Story of Development of New Herbal Medication for Bone Health.


MoUs/Licenses

Facilities & Services

Events & Activities


Campus Life @ CDRI



Important Links

Language/Style Switcher

Hindi